Evidence map›Paper›PMID 19298258›Full record

ArticleBritish journal of pharmacology2009

Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells.

Y Choi, M K Lee, S Y Lim, S H Sung, Y C Kim

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
7.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 129 citations in OpenAlex.

  1. The inhibitory effects ofFood science and biotechnology · 2026
    Article
  2. Article
  3. Evaluation of the Anti-Inflammatory and Antioxidant Properties ofPreventive nutrition and food science · 2026
    Article
  4. Article
  5. Amphiregulin in Fibrotic Diseases and Cancer.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Review
  8. Validation of Active Compound ofJournal of microbiology and biotechnology · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Phenolic Constituents of Chinese Quince Twigs (Antioxidants (Basel, Switzerland) · 2021
    Article
  17. Review
  18. Phenolic constituents from twigs ofBeilstein journal of organic chemistry · 2021
    Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Y ChoiCollege of Pharmacy and Research Institute of Pharmaceutical Science, Seoul National University, Seoul, Korea.
M K Lee
S Y Lim
S H Sung
Y C Kim
Seoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeTraditionally, the stem and root bark of Ulmus davidiana var. japonica (Ulmaceae) have been known to be anti-inflammatory in Korea. Anti-inflammatory effects of torilin, isolated from this plant and the underlying mechanisms were examined by using lipopolysaccharide (LPS)-stimulated microglial BV2 cells. EXPERIMENTAL APPROACH: The cells were treated with torilin prior to LPS exposure and the effects on pro-inflammatory enzymes, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and a pro-inflammatory cytokine, interleukin-1beta (IL-1beta) were analysed by RT-PCR, Western blot or elisa. To reveal the mechanism of action of torilin we investigated the involvement of mitogen-activated protein kinase (MAPK) cascades and their downstream transcription factors, nuclear factor-kappaB (NF-kappaB) and cyclic AMP-responsive element (CRE)-binding protein (CREB). KEY

resultsTorilin significantly reduced the LPS-induced expression of iNOS, COX-2 and IL-1beta, and the subsequent release of NO, prostaglandin E(2) and IL-1beta into culture medium. LPS stimulation of extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 MAPK was inhibited by torilin. In addition, the inhibitory effect of torilin on NF-kappaB and CREB was shown by torilin-mediated recovery of LPS-induced degradation of inhibitor kappaB-alpha and suppression of LPS-induced phosphorylation of CREB respectively. CONCLUSION AND IMPLICATIONS: This study indicates that torilin inhibited LPS-induced iNOS, COX-2 and IL-1beta via down-regulation of ERK1/2, p38 MAPK, NF-kappaB and CREB and suggests that torilin has a potential as an anti-inflammatory drug candidate.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalCell LineCyclic AMP Response Element-Binding ProteinCyclooxygenase 2Cyclooxygenase 2 InhibitorsDinoprostoneInterleukin-1betaLipopolysaccharidesMAP Kinase Signaling SystemMiceMicrogliaNF-kappa BNitric OxideNitric Oxide Synthase Type IIPhosphorylationAnti-Inflammatory Agents, Non-SteroidalCreb1 protein, mouseCyclic AMP Response Element-Binding ProteinCyclooxygenase 2Cyclooxygenase 2 InhibitorsDinoprostoneInterleukin-1betaLipopolysaccharidesNF-kappa BNitric OxideNitric Oxide Synthase Type IISesquiterpenes, Guaianetorilin

Identifiers

PMID19298258
PMCPMC2697713
OpenAlexW1702130017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.